Debt Veränderung Datum
AbbVie USD 60.75B 269M 2023-09
Acadia Pharmaceuticals USD 0 0 2022-06
Acorda Therapeutics USD 176.16M 4.67M 2023-06
Agios Pharmaceuticals USD 1.14M 84K 2022-09
ALKERMES USD 291.37M 635K 2023-09
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amgen USD 64.61B 4.15B 2023-12
Biogen USD 6.94B 348.2M 2023-12
BioMarin Pharmaceutical USD 1.09B 988K 2023-12
Cytokinetics USD 618.45M 9.43M 2023-12
Dynavax Technologies USD 222.7M 283K 2023-12
Enanta Pharmaceuticals USD 1.42M 0 2023-09
Exelixis USD 0 0 2022-03
Gilead Sciences USD 24.98B 264M 2023-09
Halozyme Therapeutics USD 1.5B 1.63M 2023-12
Incyte USD 32.6M 678K 2023-12
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 169.9M 200K 2023-09
Pfizer USD 63.6B 1.74B 2023-09
Prothena USD 0 0 2022-06
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Repligen USD 285.96M 435K 2023-09
Rigel Pharmaceuticals USD 59.66M 85K 2023-09
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Teva Pharmaceutical Industries USD 19.97B 704M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09
Xoma USD 0 0 2022-06



Neurocrine Biosciences SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.